Insider trading for Industry - General Insurance stocks based on disclosures made from Jul 01, 2026 to Jul 15, 2026

Monitor Industry - General Insurance insider transactions and discover insider buying and selling of stocks from Jul 01, 2026 to Jul 15, 2026.

The latest disclosure under SEC insider trading regulations was reported by Privia Health Group Inc., where the revocation of 21,275 Common Stock, par value $0.01 per share of common stock was executed at an average price of $27.7. This transaction was reported to the Securities and Exchange Commission on July 9, 2026.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Privia Health Group Inc
David Mountcastle EVP & Chief Financial Officer Sale of securities on an exchange or to another person at price $ 27.67 per share. 09 Jul 2026 21,275 164,853 - 27.7 588,679 Common Stock, par value $0.01 per share
Clover Health Investments Corp (Class A)
Jamie L. Reynoso CEO, Medicare Advantage Sale of securities on an exchange or to another person at price $ 4.68 per share. 08 Jul 2026 2,384 2,832,598 - 4.7 11,157 Class A Common Stock
Privia Health Group Inc
David Mountcastle EVP & Chief Financial Officer Sale of securities on an exchange or to another person at price $ 27.57 per share. 07 Jul 2026 600 186,128 - 27.6 16,542 Common Stock, par value $0.01 per share
Corebridge Fin Inc
David Ditillo Chief Information Officer Sale of securities on an exchange or to another person at price $ 30.00 per share. 06 Jul 2026 4,250 128,153 - 30 127,500 Common Stock
Clover Health Investments Corp (Class A)
Jamie L. Reynoso CEO, Medicare Advantage Sale of securities on an exchange or to another person at price $ 5.26 per share. 03 Jul 2026 6,229 2,834,982 - 5.3 32,765 Class A Common Stock
Privia Health Group Inc
M. Shawn Morris Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Jul 2026 59,037 3,328,344 - - Stock Option (Right to Purchase)
Privia Health Group Inc
M. Shawn Morris Director Sale of securities on an exchange or to another person at price $ 27.33 per share. 02 Jul 2026 59,037 76,651 - 27.3 1,613,481 Common Stock, par value $0.01 per share
Privia Health Group Inc
M. Shawn Morris Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.00 per share. 02 Jul 2026 59,037 135,688 - 2 118,074 Common Stock, par value $0.01 per share
Privia Health Group Inc
M. Shawn Morris Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 02 Jul 2026 53,722 3,274,622 - - Stock Option (Right to Purchase)
Privia Health Group Inc
M. Shawn Morris Director Sale of securities on an exchange or to another person at price $ 27.24 per share. 02 Jul 2026 53,722 68,188 - 27.2 1,463,387 Common Stock, par value $0.01 per share
Privia Health Group Inc
M. Shawn Morris Director Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.00 per share. 02 Jul 2026 53,722 130,373 - 2 107,444 Common Stock, par value $0.01 per share
Privia Health Group Inc
David Mountcastle EVP & Chief Financial Officer Sale of securities on an exchange or to another person at price $ 27.50 per share. 02 Jul 2026 24,734 186,728 - 27.5 680,185 Common Stock, par value $0.01 per share
Clover Health Investments Corp (Class A)
Andrew Toy Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 5.32 per share. 01 Jul 2026 313,476 9,609,825 - 5.3 1,667,692 Class A Common Stock
Reinsurance Grp Of America Inc
Maurice Tulloch Director Grant, award, or other acquisition of securities at price $ 215.65 per share. 01 Jul 2026 406 406 (0%) 0% 215.7 87,554 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges

This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.